For Sustainability Leaders who know that a significant share of their product carbon footprints comes from Scope 3 emissions, one of the biggest challenges is obtaining reliable data from suppliers – varying levels of data maturity, combined with concerns around commercial sensitivity, often force companies to rely on estimates.
But when it comes to corporate commitments, Market Access and carbon-related decision-making, working with such unreliable data can become increasingly uncomfortable.
When it comes to corporate commitments, Market Access and carbon-related decision-making, working with such unreliable data can become increasingly uncomfortable.
With deep hands-on experience in pharmaceutical manufacturing and supply chains, we understand the technical, operational, and commercial complexities involved in obtaining product-specific emissions data.
As an independent third party, we work directly with our clients' suppliers to extract and validate emissions data relevant to their products, while protecting commercially sensitive information and minimising the burden on their internal teams. We help:
So that our clients can deliver the executive insights required for decision-making and accelerate the impact their team makes.
Engage and support key scope 3 suppliers
As an independent third party, we work directly with our clients' suppliers to extract and validate emissions data relevant to their products, while protecting commercially sensitive information.
Data validation and audit readiness
We combine our vast experience in regulated Pharmaceutical Manufacturing with expertise in Data Standards and Validation to collect carbon data from our clients' suppliers.
Product carbon modelling for decision-making
Our PHASE platform turns high volumes of our client's product LCA data into an instant carbon decision-making tool – helping key stakeholders answer “what if?” questions in real time.
